Celldex Therapeutics (CLDX) Long-Term Investments (2016)

Celldex Therapeutics' Long-Term Investments history runs 1 years deep, the most recent figure standing at $1.8 million for Q4 2016.

• In Q4 2016, Long-Term Investments changed N/A year-over-year to $1.8 million; the TTM figure through Dec 2016 stood at $1.8 million (changed N/A YoY), while the FY2016 annual figure was $1.8 million, changed N/A from the prior year.
• Long-Term Investments for Q4 2016 stood at $1.8 million.
• The five-year high for Long-Term Investments was $1.8 million in Q4 2016, with the low at $1.8 million in Q4 2016.